Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06843096

Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

Contrast-Enhanced Mammography (CEM) in the Evaluation of Cancer of Unknown Primary Syndrome (CUP): A Multicentric Observational Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Graziella di Grezia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the role of Contrast-Enhanced Mammography (CEM) in identifying the primary tumor site in patients presenting with Cancer of Unknown Primary (CUP) syndrome. By integrating functional and anatomical imaging, the study explores CEM's diagnostic value compared to standard imaging modalities in a single-center setting.

Detailed description

The study of CUP syndrome was conducted with MRI, but we propose the study with CEM

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTContrast-Enhanced Mammography (CEM)The intervention in this study involves Contrast-Enhanced Mammography (CEM), a specialized imaging technique that combines standard mammography with contrast-enhanced imaging to detect neo-angiogenesis, which is a characteristic of malignancy. Unlike traditional mammography, CEM utilizes both low-energy and high-energy images to provide enhanced visualization of tissue vascularity, aiding in the identification of occult primary tumors, particularly in patients with Cancer of Unknown Primary (CUP) syndrome. Patients who present with CUP syndrome, suspected of having a primary breast malignancy, will undergo CEM as part of their diagnostic workup. The CEM findings will be compared with other conventional imaging modalities, including ultrasound and MRI, to assess the diagnostic accuracy of CEM in detecting primary breast tumors. The intervention will also involve correlating the imaging results with histopathological findings from biopsy or surgical specimens. This study aims to demons

Timeline

Start date
2025-01-01
Primary completion
2025-03-01
Completion
2026-01-31
First posted
2025-02-24
Last updated
2025-02-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06843096. Inclusion in this directory is not an endorsement.